Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming investor conference:
- Van Lanschot Kempen Life Sciences Conference 2023
Event Date: April 25-26, Amsterdam
| Press Release in English | 312.58 KB |
| Communiqué de presse en français | 141.66 KB |